Войти в систему Зарегистрироваться бесплатно

Navidea Biopharmaceuticals Inc Акции в свободном обращении

Что обозначает Акции в свободном обращении в Navidea Biopharmaceuticals Inc?

Акции в свободном обращении Navidea Biopharmaceuticals Inc является 0.000 0.00%

Какое определение для Акции в свободном обращении?

Акции в свободном обращении - это часть акций корпорации, которые находятся в руках государственных инвесторов, а не заблокированных акционерных капиталах.

Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded

The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.

Акции в свободном обращении компаний в Health Care сектор на NYSEMKT по сравнению с Navidea Biopharmaceuticals Inc

Что делает Navidea Biopharmaceuticals Inc?

navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de

Компании с акции в свободном обращении похож на Navidea Biopharmaceuticals Inc